Sanstone Care Teen Residential at Chesapeake
-
Services:
- Children/Adolescents
- Young Adults
- Adults
- Short-term residential
- Residential/24-hour residential
- Residential detoxification
- Long-term residential
- In-network prescribing entity
- Contingency management/motivational incentives
- 12-step facilitation
- Motivational interviewing
- Substance use disorder counseling
- Anger management
- Trauma-related counseling
- Brief intervention
- Relapse prevention
- Telemedicine/telehealth therapy
- Cognitive behavioral therapy
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine detoxification
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Relapse prevention with naltrexone
- Buprenorphine maintenance
- Clients who have experienced trauma
- Clients with co-occurring mental and substance use disorders
- Adolescents
- Methamphetamines detoxification
- Opioids detoxification
- Benzodiazepines Detoxification
- Medication routinely used during detoxification
- Cocaine Detoxification
- Alcohol Detoxification
- Self-help groups
- Employment counseling or training
- Recovery coach
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- Transportation assistance
- Suicide prevention services
- Domestic violence services, including family or partner
- Case management service
- Social skills development
- Mental health services
- Smoking not permitted
- State Substance use treatment agency
- Council on Accreditation (COA)
- National Committee for Quality Assurance (NCQA)
- The Joint Commission
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- In-network prescribing entity
- Cash or self-payment
- Federal military insurance (e.g., TRICARE)
- Private health insurance
- State-financed health insurance plan other than Medicaid
- Outcome follow-up after discharge
- Discharge Planning
- Aftercare/continuing care
- Naloxone and overdose education
- Treatment for other addiction disorder
- Breathalyzer or blood alcohol testing
- Drug or alcohol urine screening
- Metabolic syndrome monitoring
- Naltrexone (extended-release, injectable)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Disulfiram
- Buprenorphine with naloxone
- Medication for mental disorders
- Acamprosate (CampralĀ®)
- Clonidine
- Comprehensive substance use assessment
- Screening for mental disorders
- Comprehensive mental health assessment
- Interim services for clients
- Screening for substance use
- Outreach to persons in the community
- Screening for tobacco use
- Vaping not permitted
- Female
- Male
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Private for-profit organization
- Detoxification
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Group counseling
- Substance use disorder education
- Marital/couples counseling
- Vocational training or educational support (for example, high school coursework, GED preparation, etc.)
- Individual counseling
- Smoking/vaping/tobacco cessation counseling
- Family counseling
Age Groups Accepted
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Opioid Medications Source
Treatment Approaches
Type of Opioid Treatment
Special Programs/Groups Offered
Detoxification (medical withdrawal) Services
Recovery Support Services
Ancillary Services
Facility Smoking Policy
License/Certification/Accreditation
Type of Alcohol Use Disorder Treatment
External Source of Medications Used for Alcohol Use Disorder Treatment
Payment/Insurance/Funding Accepted
Transitional Services
Other Services
Testing
Pharmacotherapies
Assessment/Pre-treatment
Facility Vaping Policy
Gender Accepted
Opioid Medications used in Treatment
Facility Operation (e.g., Private, Public)
Type of Care
Education and Counseling Services